SCHEMBL20142385

SCHEMBL20142385

[CH]1CCCOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4358750 0.91 ALDH1A1 (0.30)
SCHEMBL420475 0.90
SCHEMBL416669 0.88
SCHEMBL1560426 0.88
SCHEMBL7609600 0.85 ALDH1A1 (0.37)
SCHEMBL4357113 0.85 ALDH1A1 (0.37)
SCHEMBL4363377 0.85 ALDH1A1 (0.37)
SCHEMBL4362802 0.85 ALDH1A1 (0.37)
SCHEMBL4354336 0.85 ALDH1A1 (0.37)
SCHEMBL4358871 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159522-A1 BCL-2 INHIBITOR BEONE MEDICINES I GMBH (CH) 2023-05-25 US claimed
CN-114425024-A Stabilized compositions containing hydroquinone or derivatives thereof 株式会社LG生活健康 2022-05-03 CN claimed
CN-114072402-A Pyridine derivatives as dual FGFR and VEGFR inhibitors 南京明德新药研发有限公司 2022-02-18 CN claimed
CN-113490667-A Imidazopyridine derivatives as dual FGFR and VEGFR inhibitors 南京明德新药研发有限公司 2021-10-08 CN claimed
WO-2021119254-A1 ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 VANDERBILT UNIVERSITY (US) 2021-06-17 WO claimed
WO-2020081840-A1 METHODS OF TREATING CANCER WITH ARYL HYDROCARBON RECEPTOR ANTAGONISTS Magenta Therapeutics Inc. (US) 2020-04-23 WO claimed
CN-110770214-A Heterocyclic P2X7 antagonists 阿克萨姆股份公司 2020-02-07 CN claimed
CN-1627944-A Substituted quinazolin-4-ylamine analogues as capsaicin modulators NEUROGEN CORP (US) 2005-06-15 CN claimed
CN-1408015-A Pigment preparations having improved safety CLARIANT GMBH (DE) 2003-04-02 CN claimed
CN-111542523-B Heterocyclic compounds as PRMT5 inhibitors 朱比连特埃皮斯科瑞有限责任公司 2024-03-29 CN disclosed
CN-117794992-A Process for modifying aqueous polymer latex 巴斯夫欧洲公司 2024-03-29 CN disclosed
CN-114302886-B Triazolopyridazine derivative, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2024-03-22 CN disclosed
CN-117715903-A Cereblon binding compounds, compositions thereof, and methods for their use in therapy 新基公司 2024-03-15 CN disclosed
CN-112424181-B Substituted condensed thiophenes as STING modulators 希泰克斯特私人有限公司 2024-02-27 CN disclosed
CN-1220733-C Pigment preparations that are improved with regard to safety regulations CLARIANT GMBH (DE) 2005-09-28 CN disclosed
CN-1553773-A Thiazolo [4, 5-b ] pyridines as fungicides �����ɷ� 2004-12-08 CN disclosed
CN-1497344-A Chemical amplification pasitive corrosion stability compound 住友化学工业株式会社 2004-05-19 CN disclosed
CN-1408015-A Pigment preparations having improved safety CLARIANT GMBH (DE) 2003-04-02 CN disclosed
CN-1382045-A Inhibitor for 20-hydroxy-eicosatetraenoic acid enzyme TAISHO PHARMACEUTICAL CO LTD (JP) 2002-11-27 CN disclosed
CN-1252802-A Writable and eresable high-density optical storage media CIBA SC HOLDING AG (CH) 2000-05-10 CN disclosed